Drug Profile
LND 101001
Alternative Names: LND101001Latest Information Update: 24 Oct 2018
Price :
$50
*
At a glance
- Originator Lupin
- Class Antidementias; Nootropics
- Mechanism of Action Alpha7 nicotinic acetylcholine receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 24 Oct 2018 No development reported - Phase-II for Alzheimer's disease (In the elderly, In adults) in Spain, Croatia, Czech Republic, Poland, United Kingdom, Lithuania, Italy (PO)